Research Article

Emergency Tracheal Intubation in Patients with COVID-19: Experience from a UK Centre

Table 2

Tracheal intubation data. Data are expressed as n/N (%) or median and interquartile range (IQR).

Location of tracheal intubation

Remote35/53 (66%)
 Emergency department20 (38%)
 General medical ward15 (28%)

Nonremote18/53 (34%)
 Intensive care unit9 (17%)
 Operating theatres9 (17%)

Primary intubator/laryngoscopist

Consultant49/53 (92%)
Senior trainee4/53 (8%)

Number of tracheal intubation attempts

One45/53 (85%)
Two7/53 (13%)
Three1/53 (2%)
Failed0/53 (0%)

Laryngoscopy technique

Direct laryngoscopy4/53 (8%)
Videolaryngoscopy42/53 (79%)
Not specified7/53 (13%)
Stylet45/53 (85%)
Bougie6/53 (11%)
Adjunct not required2/53 (4%)
Cricoid pressure22/53 (42%)

Induction drugs

Induction agent
 Propofol46/53 (87%)
 Ketamine4/53 (8%)
 Thiopentone1/53 (2%)
 Not specified2/53 (4%)

Median dose of commonly used drugs
 Fentanyl 94% (50/53)2.5 mcg/kg (IQR 0.66)
 Propofol 87% (46/53)1.22 mg/kg (IQR 0.7)
 Rocuronium 94.3% (50/53)1.20 mg/kg (IQR 0.27)